Immuno Oncology Talks
The Immuno Oncology Talks aims to shed light on cutting edge science that is evolving with new immunological therapeutic approaches for the treatment of cancers. The podcasts consist of discussions with leading experts and are intended for anyone that would like to broaden their knowledge of what is happening in this rapidly expanding field. MAT-BE-2200553 (ver 1.0) 09 2022.
Episodes
11 episodes
Looking into the horizon of CAR-T cell therapies
In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Marit Inderberg and Dr Sébastien Wälch...
•
Season 2
•
Episode 11
•
33:51
Oncogenes in relation to immune responses
In our tenth episode of the “Immuno Oncology Talks”, we will discuss oncogenes in relation to immune responses with our guest, Professor Juha Klefström, from the Finnish Cancer Institute at the University of Helsinki, Finland. Professor K...
•
Season 2
•
Episode 10
•
27:41
Cancer Immunotherapy and the role of Microbiome
In our ninth episode of the “Immuno Oncology Talks”, we will discuss the rapidly evolving field of the microbiome in cancer immunotherapy with our guest, Professor Jeroen Raes, from the Department of Microbiology, Immunology and Transplantation...
•
Season 2
•
Episode 9
•
27:29
Cancer cell and gene therapies and the challenges to access the market
In our eight episode of the “Immuno Oncology Talks”, we will hear about the current challenges of getting cancer cell and gene therapies on the market from a health economic perspective. Our guest, Professor Cornelis Boersma, from Univer...
•
Season 2
•
Episode 8
•
29:24
Therapeutic RNA vaccines in cancer Immunotherapy
This episode, the seventh of our “Immuno Oncology Talks”, will be covering “Therapeutic RNA vaccines in cancer immunotherapy”, with our two guests, Professor Karine Breckpot and Professor Kris Thielemans, from the Laborator...
•
Season 2
•
Episode 7
•
29:55
Non-viral RNA treatment approaches in Cancer Immunotherapy
In our sixth episode of “Immuno Oncology Talks”, we will discuss non-viral RNA treatment approaches in cancer immunotherapy with our guest, professor Karine Breckpot from the Laboratory for Molecular and Cellular Therapy, Department of Biomedic...
•
Season 2
•
Episode 6
•
29:45
Adoptive therapy with engineered T cell receptors
In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the Netherlands. Professor Debets research...
•
Season 1
•
Episode 5
•
29:32
Targeting Neutrophils as effector cells in cancer therapy
The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in cancer therapy. Professor Marjolein van Egmond s...
•
Season 1
•
Episode 4
•
25:24
Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy
In the third episode of the “Immuno Oncology Talks”, we have had the pleasure to discuss tumor infiltrating lymphocytes for adoptive cell therapy with Professor Inge Marie Svane from the National Center for Cancer Immune Therapy in Denmark. Pro...
•
Season 1
•
Episode 3
•
27:05
NK cell-based cancer immunotherapies
In our second episode of the “Immuno Oncology Talks”, Associate Professor Evren Alici, from the Karolinska Institutet in Sweden, was invited to discuss NK cell-based cancer immunotherapies, accompanied by his colleague Professor Hans-Gustaf Lju...
•
Season 1
•
Episode 2
•
32:54
Biology of Natural Killer (NK) cells
The first episode in the “Immuno Oncology Talks” is about the biology of Natural Killer (NK) cells. The interview is conducted with Professor Hans-Gustaf Ljunggren at Karolinska Institutet in Sweden together with his colleague Associate profess...
•
Season 1
•
Episode 1
•
16:51